Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
T cell proliferative responses to hepatitis B virus-encoded envelope antigen (S + preS2 + preS1), recombinant core antigen (HBcAg), and natural hepatitis B e antigen (HBeAg) were examined in 22 HBeAg-positive patients with chronic type B hepatitis and 17 healthy hepatitis B surface antigen (HBsAg) carriers. The results showed that HBeAg-positive patients had (a) higher levels of T cell responses to HBcAg/HBeAg than those of healthy HBsAg carriers (P less than 0.001 and P less than 0.01, respectively); (b) a further increase in these T cell responses during acute exacerbations (P less than 0.05 and P less than 0.05, respectively); (c) subsidence in the T cell responses to HBcAg/HBeAg after recovery from acute exacerbations and HBeAg seroconversion, whereas the responses would persist at high levels if the patients did not enter a clinical remission; and (d) low levels of T cell responses to S + preS2 + preS1 either before or after HBeAg seroconversion. The appearance of increasing T cell responses to HBcAg/HBeAg usually occurred in the early phase of acute exacerbations. These findings imply that HBcAg/HBeAg-specific T cells play an important role in the exacerbations of chronic hepatitis B and in HBeAg seroconversion. HBcAg/HBeAg-specific precursor T cell frequencies were serially studied in selected cases by limiting dilution assay. Elevation (two- to fourfold) of HBcAg/HBeAg-specific precursor T cell frequencies contributed to the increase of HBcAg/HBeAg-specific T cell proliferation during acute exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
PCR protocols — A guide to methods and applications
U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,702
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Self-citationSeparation of leukocytes from blood and bone marrow
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 2,696
The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel Filtration
Mogensen, C. E. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076979 · Cited by 2,654
Taswell, C. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1614 · Cited by 1,212
Carman, W. F., Hadziyannis, S., Mcgarvey, M. J., Jacyna, M. R., Karayiannis, P., Makris, A., & Thomas, H. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90713-7 · Cited by 1,200
Release of Infectious Epstein-Barr Virus by Transformed Marmoset Leukocytes
Miller, G., & Lipman, M. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.1.190 · Cited by 941
Perrillo, R. P., Schiff, E. R., Davis, G. L., Bodenheimer, H. C., Lindsay, K., Payne, J., Dienstag, J. L., O'Brien, C., Tamburro, C., Jacobson, I. M., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008023230503 · Cited by 840
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich, D. R., Jones, J. E., Hughes, J. L., Price, J., Raney, A. K., & McLachlan, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6599 · Cited by 580
Cited by
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Self-citationImmunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Management of hepatitis B: 2000—Summary of a workshop
Lok, A. S., Heathcote, E. J., & Hoofnagle, J. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.24839 · Cited by 776
Management of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
Yim, H. J., & Lok, A. S.-F. (2006) · Hepatology · doi:10.1002/hep.20956 · Cited by 545
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
Boni, C., Bertoletti, A., Penna, A., Cavalli, A., Pilli, M., Urbani, S., Scognamiglio, P., Boehme, R., Panebianco, R., Fiaccadori, F., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3731 · Cited by 459
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia
Thursz, M. R., Kwiatkowski, D., Allsopp, C. E. M., Greenwood, B. M., Thomas, H. C., & Hill, A. V. S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321604 · Cited by 431
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061287 · Cited by 421
Perrillo, R. P. (2001) · Gastroenterology · doi:10.1053/gast.2001.22461 · Cited by 421
Exploring the Biological Basis of Hepatitis B E Antigen in Hepatitis B Virus Infection
Milich, D., & Liang, J. T. (2003) · Hepatology · doi:10.1053/jhep.2003.50453 · Cited by 393
Webster, G. J. M., Reignat, S., Brown, D., Ogg, G. S., Jones, L., Seneviratne, S. L., Williams, R., Dusheiko, G., & Bertoletti, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5707-5719.2004 · Cited by 387
The immune response during hepatitis B virus infection
Bertoletti, A., & Gehring, A. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81920-0 · Cited by 385
Immune Pathogenesis of Hepatocellular Carcinoma
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., & Chisari, F. V. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.341 · Cited by 373
From Hepatitis to Hepatoma: Lessons from Type B Viral Hepatitis
Chen, D.-S. (1993) · Science · doi:10.1126/science.8211155 · Cited by 325
Self-citationHepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management
Chang, M.-L., & Liaw, Y.-F. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.033 · Cited by 296
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.
Rehermann, B., Lau, D., Hoofnagle, J. H., & Chisari, F. V. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118592 · Cited by 294
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Sangro, B., Chan, S. L., Meyer, T., Reig, M., El-Khoueiry, A., & Galle, P. R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.021 · Cited by 293
Naturally Occurring Variants of Hepatitis B Virus
Günther, S., Fischer, L., Pult, I., Sterneck, M., & Will, H. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60298-5 · Cited by 255
Vanwolleghem, T., Hou, J., van Oord, G., Andeweg, A. C., Osterhaus, A. D. M. E., Pas, S. D., Janssen, H. L. A., & Boonstra, A. (2015) · Hepatology · doi:10.1002/hep.27805 · Cited by 110
Hepatitis B virus infection, its sequelae, and prevention by vaccination
Huang, L.-M., Lu, C.-Y., & Chen, D.-S. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.12.013 · Cited by 51
Self-citation
Metadata
- Authors
- Tsai, S. L., Chen, P. J., Lai, M. Y., Yang, P. M., Sung, J. L., Huang, J. H., Hwang, L. H., Chang, T. H., & Chen, D. S.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-01-01
- Volume
- 89
- Issue
- 1
- Pages
- 87-96
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2107451615
- Cited by
- 287
- References
- 24
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.